about
Current and emerging therapies in multiple sclerosis: a systematic reviewPediatric transverse myelitis.Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosisTop-down mass spectrometry on tissue extracts and biofluids with isoelectric focusing and superficially porous silica liquid chromatography.Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencingModulation of immune function occurs within hours of therapy initiation for multiple sclerosisElevated CNS inflammation in patients with preclinical Alzheimer's disease.The neurologic manifestations of systemic lupus erythematosus.Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity.A surprisingly low prevalence of demonstrable stress urinary incontinence and pelvic organ prolapse in women with multiple sclerosis followed at a tertiary neurogenic bladder clinic.Transverse myelitis.Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis.Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab.Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases.Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis.Current and emerging multiple sclerosis therapeutics.Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.Analysis of 30 Spinal Angiograms Falsely Reported as Normal in 18 Patients with Subsequently Documented Spinal Vascular Malformations.Uhthoff's phenomena in MS--clinical features and pathophysiology.Fatigue, emotional functioning, and executive dysfunction in pediatric multiple sclerosis.Cognitive functioning in pediatric transverse myelitis.Pearls: multiple sclerosis.Progressive multifocal leukoencephalopathy after fingolimod treatment.Peripheral nerve involvement in adult and pediatric patients with central nervous system inflammatory disease--reply.A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentationsAdmixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestryNew onset transverse myelitis diagnostic accuracy and patient experiencesAnticipated benefits and surprising effects of daclizumab in multiple sclerosisOptic neuritis: A mechanistic view
P50
Q29010983-E990DF37-BD2D-40F9-A8AD-423054705A3AQ31125356-754B0631-B531-4254-A1DB-BD949BF31F77Q33445437-8F47B834-212A-4DFA-8881-F6822D986699Q34409297-0B79F71A-59BB-44FA-AAF4-7BF180E38A1EQ34612943-9C3FF61E-256D-4557-A0C9-BEC7EECFBA1EQ35001403-8ED7113C-4D5D-46AA-A352-1F70672D6BC5Q35077861-77EAE7DA-BFC0-435D-9B26-F1333D0E6993Q36384476-3112D89A-7878-4F4B-A957-61C06986C0B6Q36433030-E2904080-E713-4936-BBDE-6A65B65EB457Q36791390-27A440AC-C473-45BD-945A-5F0E375EF873Q37459897-7BF2254D-BA8E-4EA7-AE9F-1821436B92C0Q37476594-0F2A9155-AE44-4856-B506-DCEA9874D698Q37536318-94B4B888-4E2D-48A2-BC93-56BE841150A0Q37645910-4106091E-5534-4994-A7FA-5DEDAF95BC59Q37645937-CC5FE018-F769-4266-BF2E-748478C0625BQ37661189-41848982-A978-4082-BCC2-B340945E77EBQ37995305-7E10E41F-5B24-492B-8D1C-A92C3A9B0E6CQ38047592-D2314320-F7BE-4CA1-9E06-CC28A6A0B879Q38063024-BE863672-F023-4B85-8F27-EBF2F67064AFQ38150405-7DE2322F-C9BF-4266-969A-F744F9715CB6Q38234844-3B8D761F-E75B-4FD5-9D30-269649D54868Q38639993-9369204A-337B-42D4-A346-EC47353E2F31Q39012188-7AE563CC-AC82-48FF-BF41-F60E21721F76Q42230778-51D82D9A-ED1D-4E33-8C10-7DCF8A7F059BQ42513254-2C2E6D5B-48A3-4FEF-9045-777A38BFCF07Q44787153-D0276AA1-ADF8-48ED-BD67-89266CC1E00BQ46042022-E0A29009-E408-4AA2-A657-3570006B131FQ48092211-4219CC86-0920-403D-99DE-EBFAA18BE520Q48231773-EFBDAA45-7124-486D-9362-BD62BD70DDF4Q48341423-AF43D20D-9CA5-4474-9E79-44832D4C68EEQ48576302-08278277-1585-49F5-A4B6-950A96F56BB7Q51724526-2ED17BC4-700C-4E9F-BD3D-0FBFD0D679FDQ52718488-A25CAAC1-81B6-4794-ADB7-F3CDE88A9B07Q53646029-588C0E83-C1AF-4F5D-AB31-508FB1D0D1F5Q55107890-45847568-E524-4BBB-87D5-2CD8FE0A2F5AQ57298161-B5890193-9640-45F3-96E0-49EDB492EFA3Q61814662-F3218591-1CEE-407C-8DF0-56AB636619EDQ64040714-9898941B-0475-440F-B6BE-BD10413CAE01Q82938471-8FC40214-A3BA-475A-A87D-AC89EDD6D440Q84229882-98B9AE2D-6FFD-4C1E-A7FD-084AC159DDF8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Benjamin M. Greenberg
@ast
Benjamin M. Greenberg
@en
Benjamin M. Greenberg
@es
Benjamin M. Greenberg
@nl
Benjamin M. Greenberg
@sl
type
label
Benjamin M. Greenberg
@ast
Benjamin M. Greenberg
@en
Benjamin M. Greenberg
@es
Benjamin M. Greenberg
@nl
Benjamin M. Greenberg
@sl
prefLabel
Benjamin M. Greenberg
@ast
Benjamin M. Greenberg
@en
Benjamin M. Greenberg
@es
Benjamin M. Greenberg
@nl
Benjamin M. Greenberg
@sl
P106
P1153
8862389300
P21
P31
P496
0000-0002-2091-8201